Qingdao NovelBeam Technology Co. Ltd. A (688677) - Total Assets
Based on the latest financial reports, Qingdao NovelBeam Technology Co. Ltd. A (688677) holds total assets worth CN¥1.63 Billion CNY (≈ $237.83 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Qingdao NovelBeam Technology Co. Ltd. A - Total Assets Trend (2013–2025)
This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's total assets have evolved over time, based on quarterly financial data. Also see 688677 market cap for the company's overall valuation and market capitalisation.
Qingdao NovelBeam Technology Co. Ltd. A - Asset Composition Analysis
Current Asset Composition (December 2025)
Qingdao NovelBeam Technology Co. Ltd. A's total assets of CN¥1.63 Billion consist of 63.2% current assets and 36.9% non-current assets. Review how much debt does Qingdao NovelBeam Technology Co. Ltd. A carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 36.0% |
| Accounts Receivable | CN¥106.67 Million | 6.5% |
| Inventory | CN¥260.38 Million | 15.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥28.77 Million | 1.8% |
| Goodwill | CN¥3.61 Million | 0.2% |
Asset Composition Trend (2013–2025)
This chart illustrates how Qingdao NovelBeam Technology Co. Ltd. A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for Qingdao NovelBeam Technology Co. Ltd. A for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Qingdao NovelBeam Technology Co. Ltd. A's current assets represent 63.2% of total assets in 2025, an increase from 40.1% in 2013.
- Cash Position: Cash and equivalents constituted 36.0% of total assets in 2025, up from 14.5% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 11.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 15.9% of total assets.
Qingdao NovelBeam Technology Co. Ltd. A Competitors by Total Assets
Key competitors of Qingdao NovelBeam Technology Co. Ltd. A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Gan & Lee Pharmaceuticals Co Ltd
SHG:603087
|
China | CN¥12.68 Billion |
|
Andon Health Co Ltd
SHE:002432
|
China | CN¥29.91 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
China | CN¥2.42 Billion |
|
Pegavision
TW:6491
|
Taiwan | NT$16.17 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Embecta Corp
NASDAQ:EMBC
|
USA | $1.27 Billion |
Qingdao NovelBeam Technology Co. Ltd. A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.17 | 5.88 | 19.61 |
| Quick Ratio | 3.86 | 4.64 | 18.47 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥816.83 Million | CN¥777.47 Million | CN¥813.48 Million |
Qingdao NovelBeam Technology Co. Ltd. A - Advanced Valuation Insights
This section examines the relationship between Qingdao NovelBeam Technology Co. Ltd. A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.48 |
| Latest Market Cap to Assets Ratio | 0.84 |
| Asset Growth Rate (YoY) | 12.0% |
| Total Assets | CN¥1.63 Billion |
| Market Capitalization | $1.37 Billion USD |
Valuation Analysis
Near Book Valuation: The market values Qingdao NovelBeam Technology Co. Ltd. A's assets close to their book value (0.84x), suggesting investors view the company's assets at approximately fair value.
Rapid Asset Growth: Qingdao NovelBeam Technology Co. Ltd. A's assets grew by 12.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Qingdao NovelBeam Technology Co. Ltd. A (2013–2025)
The table below shows the annual total assets of Qingdao NovelBeam Technology Co. Ltd. A from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥1.63 Billion ≈ $239.21 Million |
+11.96% |
| 2024-12-31 | CN¥1.46 Billion ≈ $213.66 Million |
+4.68% |
| 2023-12-31 | CN¥1.39 Billion ≈ $204.11 Million |
+0.09% |
| 2022-12-31 | CN¥1.39 Billion ≈ $203.92 Million |
+17.92% |
| 2021-12-31 | CN¥1.18 Billion ≈ $172.93 Million |
+183.19% |
| 2020-12-31 | CN¥417.31 Million ≈ $61.07 Million |
+26.53% |
| 2019-12-31 | CN¥329.82 Million ≈ $48.26 Million |
+20.86% |
| 2018-12-31 | CN¥272.90 Million ≈ $39.93 Million |
+18.21% |
| 2017-12-31 | CN¥230.86 Million ≈ $33.78 Million |
+9.30% |
| 2016-12-31 | CN¥211.21 Million ≈ $30.91 Million |
+12.71% |
| 2015-12-31 | CN¥187.39 Million ≈ $27.42 Million |
+13.34% |
| 2014-12-31 | CN¥165.34 Million ≈ $24.19 Million |
+13.58% |
| 2013-12-31 | CN¥145.56 Million ≈ $21.30 Million |
-- |
About Qingdao NovelBeam Technology Co. Ltd. A
Qingdao NovelBeam Technology Co.,Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and opt… Read more